This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2004 Jul:87 Suppl 2:235-42.

doi: 10.1111/j.1741-6892.2004.00495.x.

Globin gene transfer as a potential treatment for the beta-thalassaemias and sickle cell disease

M Sadelain¹

Affiliations

PMID: 15209924
DOI: 10.1111/j.1741-6892.2004.00495.x

Review

Globin gene transfer as a potential treatment for the beta-thalassaemias and sickle cell disease

M Sadelain. Vox Sang. 2004 Jul.

. 2004 Jul:87 Suppl 2:235-42.

doi: 10.1111/j.1741-6892.2004.00495.x.

Author

M Sadelain¹

Affiliation

¹ Laboratory of Gene Transfer and Gene Expression, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. m-sadelain@ski.mskcc.org

PMID: 15209924
DOI: 10.1111/j.1741-6892.2004.00495.x

No abstract available

PubMed Disclaimer

Similar articles

Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia.
Sadelain M. Sadelain M. Curr Opin Hematol. 2006 May;13(3):142-8. doi: 10.1097/01.moh.0000219658.57915.d4. Curr Opin Hematol. 2006. PMID: 16567956 Review.
On the road to gene therapy for beta-thalassemia and sickle cell anemia.
Bank A. Bank A. Pediatr Hematol Oncol. 2008 Jan-Feb;25(1):1-4. doi: 10.1080/08880010701773829. Pediatr Hematol Oncol. 2008. PMID: 18231949 Review.
Progress toward the genetic treatment of the beta-thalassemias.
Sadelain M, Lisowski L, Samakoglu S, Rivella S, May C, Riviere I. Sadelain M, et al. Ann N Y Acad Sci. 2005;1054:78-91. doi: 10.1196/annals.1345.010. Ann N Y Acad Sci. 2005. PMID: 16339654 Review.
Globin gene transfer for treatment of the beta-thalassemias and sickle cell disease.
Sadelain M, Rivella S, Lisowski L, Samakoglu S, Rivière I. Sadelain M, et al. Best Pract Res Clin Haematol. 2004 Sep;17(3):517-34. doi: 10.1016/j.beha.2004.08.002. Best Pract Res Clin Haematol. 2004. PMID: 15498721 Review.
Correction of sickle cell disease in transgenic mouse models by gene therapy.
Pawliuk R, Westerman KA, Fabry ME, Payen E, Tighe R, Bouhassira EE, Acharya SA, Ellis J, London IM, Eaves CJ, Humphries RK, Beuzard Y, Nagel RL, Leboulch P. Pawliuk R, et al. Science. 2001 Dec 14;294(5550):2368-71. doi: 10.1126/science.1065806. Science. 2001. PMID: 11743206

See all similar articles

Cited by

Production of beta-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous beta(0)39 thalassemia patients.
Salvatori F, Breveglieri G, Zuccato C, Finotti A, Bianchi N, Borgatti M, Feriotto G, Destro F, Canella A, Brognara E, Lampronti I, Breda L, Rivella S, Gambari R. Salvatori F, et al. Am J Hematol. 2009 Nov;84(11):720-8. doi: 10.1002/ajh.21539. Am J Hematol. 2009. PMID: 19810011 Free PMC article.
Lenti in red: progress in gene therapy for human hemoglobinopathies.
von Kalle C, Baum C, Williams DA. von Kalle C, et al. J Clin Invest. 2004 Oct;114(7):889-91. doi: 10.1172/JCI23132. J Clin Invest. 2004. PMID: 15467825 Free PMC article.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Wiley
Medical
- MedlinePlus Health Information